Department of Health and Human Services
Food and Drug Administration
- [Docket No. FDA-2018-N-2727]
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA or Agency) is announcing that a collection of information entitled “Institutional ( printed page 3409) Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-5733, PRAStaff@fda.hhs.gov.